Os05g0539400 Antibody

What is Os05g0539400 and why is it significant in plant research?

Os05g0539400 refers to a specific gene locus in rice (Oryza sativa) that encodes a protein with UniProt accession number Q0DGD7. This protein is significant in plant research because it's part of the rice genome that has been fully sequenced and represents an important model organism for studying monocotyledonous plants. Understanding specific proteins like Os05g0539400 contributes to our knowledge of plant development, stress responses, and potential applications in crop improvement .

What are the primary characteristics of the Os05g0539400 antibody?

The Os05g0539400 antibody is a polyclonal antibody raised in rabbits against recombinant Oryza sativa subsp. japonica Os05g0539400 protein. It demonstrates the following key characteristics:

• Isotype: IgG

• Clonality: Polyclonal

• Form: Liquid

• Conjugate: Non-conjugated

• Storage Buffer: 0.03% Proclin 300, 50% Glycerol, 0.01M PBS, pH 7.4

• Purification Method: Antigen Affinity Purified

• Validated Applications: ELISA and Western Blot (WB)

What are the recommended storage conditions for the Os05g0539400 antibody?

For optimal stability and performance, the Os05g0539400 antibody should be stored at either -20°C or -80°C upon receipt. It's crucial to avoid repeated freeze-thaw cycles as these can lead to protein denaturation and loss of antibody activity. When working with the antibody, it should be thawed completely but kept cold (on ice) during use. The product is typically shipped at 4°C and should be stored immediately at the recommended temperature upon arrival to maintain its efficacy .

Which experimental applications have been validated for the Os05g0539400 antibody?

The Os05g0539400 antibody has been validated for two main experimental applications:

• Enzyme-Linked Immunosorbent Assay (ELISA) - For quantitative detection of the Os05g0539400 protein in solution

• Western Blot (WB) - For identifying and confirming the presence of the Os05g0539400 protein in tissue or cell lysates

These applications have been specifically tested to ensure the antibody's performance in identifying the target antigen .

How does antibody cross-reactivity impact experimental design when studying Os05g0539400 in different plant species?

Cross-reactivity is a critical consideration when using the Os05g0539400 antibody across different plant species. While this antibody is specifically designed for Oryza sativa subsp. japonica (rice), researchers should conduct preliminary validation when applying it to related species. Drawing from similar plant antibodies like the Os05g0149400 antibody, we can infer potential cross-reactivity patterns:

When designing experiments involving multiple species, researchers should:

• Perform epitope sequence analysis to predict cross-reactivity

• Include appropriate positive and negative controls

• Validate antibody specificity via Western blot before proceeding with primary experiments

• Consider pre-absorption with non-target proteins if cross-reactivity is observed

What are the potential mechanisms behind false positive and false negative results when using the Os05g0539400 antibody in immunoassays?

Several mechanisms can contribute to false results when using the Os05g0539400 antibody:

False Positives:

• Cross-reactivity with structurally similar proteins, particularly in complex plant extracts

• Non-specific binding to high-abundance proteins

• Sample contamination with bacterial or fungal proteins

• Insufficient blocking during immunoassays

• Secondary antibody cross-reactivity

False Negatives:

• Epitope masking due to protein modifications or conformational changes

• Protein degradation during sample preparation

• Insufficient antigen concentration below detection threshold

• Interference from sample components inhibiting antibody-antigen interaction

• Antibody degradation due to improper storage or handling

To minimize these issues, researchers should implement rigorous validation protocols including multiple controls, optimization of antibody concentration, and confirmation using alternative detection methods .

How can computational approaches be integrated with Os05g0539400 antibody-based research for improved target validation?

Integration of computational approaches with Os05g0539400 antibody research can significantly enhance target validation through:

• Epitope Prediction and Analysis:

  • Computational algorithms can predict antibody binding sites on the Os05g0539400 protein

  • This helps understand potential cross-reactivity with similar proteins

  • Enables rational design of blocking peptides for specificity validation

• Machine Learning for Binding Prediction:

  • Active learning strategies, as demonstrated in antibody-antigen binding research, can predict binding affinity and specificity

  • These models can reduce experimental iterations by 35% and accelerate the learning process

  • Such approaches help optimize antibody concentration and assay conditions

• Structural Biology Integration:

  • Protein structure modeling helps visualize antibody-antigen interactions

  • Molecular dynamics simulations can assess binding stability

  • These insights guide experimental design and interpretation of results

• Database Mining and Comparison:

  • Leveraging antibody data repositories to compare with similar antibodies

  • Identifying potential off-target effects based on homology

  • Establishing confidence levels for experimental observations

Implementation of these computational approaches transforms traditional antibody-based research into a more efficient and predictive framework, reducing experimental iterations while increasing confidence in results.

What is the optimal protocol for using Os05g0539400 antibody in Western Blot applications?

The following optimized protocol for Western Blot applications with Os05g0539400 antibody incorporates methodological considerations specific to plant proteins:

Sample Preparation:

• Extract total protein from rice tissues using a buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, and protease inhibitor cocktail

• Homogenize tissue (1:3 w/v ratio) and centrifuge at 12,000 × g for 15 minutes at 4°C

• Collect supernatant and determine protein concentration using Bradford assay

• Mix samples with Laemmli buffer and heat at 95°C for 5 minutes

Gel Electrophoresis and Transfer:

• Load 20-50 μg protein per lane on 10-12% SDS-PAGE gel

• Run gel at 100V until dye front reaches bottom

• Transfer proteins to PVDF membrane at 100V for 1 hour in cold transfer buffer

Immunoblotting:

• Block membrane with 5% non-fat dry milk in TBST for 1 hour at room temperature

• Incubate with Os05g0539400 antibody at 1:1000 dilution in blocking buffer overnight at 4°C

• Wash membrane 3 times with TBST, 5 minutes each

• Incubate with HRP-conjugated secondary antibody (anti-rabbit IgG) at 1:5000 dilution for 1 hour

• Wash membrane 3 times with TBST, 5 minutes each

• Develop using ECL substrate and image using appropriate detection system

Critical Considerations:

• Include a positive control (recombinant Os05g0539400 protein if available)

• Include a negative control (non-rice plant extract or Os05g0539400 knockout/knockdown sample)

• Expected molecular weight should be confirmed based on protein sequence analysis

• Multiple extraction methods may be necessary to optimize protein recovery

How can the Os05g0539400 antibody be effectively used in immunoprecipitation studies?

While immunoprecipitation (IP) is not explicitly listed among the validated applications for the Os05g0539400 antibody, researchers might adapt it for this purpose following careful validation. The following methodology provides a framework for developing an IP protocol:

Preparation Steps:

• Prepare fresh plant tissue lysate in a non-denaturing lysis buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 0.5% sodium deoxycholate, protease inhibitors)

• Clarify lysate by centrifugation at 14,000 × g for 15 minutes at 4°C

• Pre-clear lysate with Protein A/G beads for 1 hour at 4°C

Immunoprecipitation Procedure:

• Add Os05g0539400 antibody to pre-cleared lysate (2-5 μg antibody per 500 μg total protein)

• Incubate overnight with gentle rotation at 4°C

• Add 30 μl Protein A/G beads and incubate for 2-4 hours at 4°C

• Collect beads by centrifugation and wash 4 times with cold wash buffer

• Elute bound proteins by boiling in SDS sample buffer or using a specific elution buffer

Validation and Controls:

• Input control: Save a portion of pre-cleared lysate

• IgG control: Perform parallel IP with non-specific rabbit IgG

• Western blot verification: Analyze immunoprecipitated samples using the same or different Os05g0539400 antibody

• Mass spectrometry: Consider confirming identity of precipitated proteins

Optimization Considerations:

• Antibody concentration may need adjustment based on target abundance

• Cross-linking antibody to beads can reduce antibody contamination in eluates

• Native conditions versus partially denaturing conditions may affect epitope accessibility

• Addition of detergents or salt concentration adjustments might improve specificity

What are the best practices for optimizing Os05g0539400 antibody use in immunohistochemistry of plant tissues?

While immunohistochemistry (IHC) is not listed among the validated applications for Os05g0539400 antibody, researchers interested in adapting it for this purpose should consider these methodological approaches:

Tissue Preparation and Fixation:

• Collect fresh plant tissue and fix immediately in 4% paraformaldehyde in PBS for 12-24 hours

• Dehydrate gradually through ethanol series (30%, 50%, 70%, 85%, 95%, 100%)

• Clear in xylene and embed in paraffin

• Section tissues at 5-10 μm thickness

Antigen Retrieval Optimization:

• Test multiple antigen retrieval methods:

  • Heat-induced epitope retrieval: Citrate buffer (pH 6.0) or Tris-EDTA (pH 9.0)

  • Enzymatic retrieval: Proteinase K (10 μg/ml) for 15 minutes

• Compare retrieval efficiency through pilot experiments

Immunostaining Protocol:

• Deparaffinize and rehydrate sections

• Perform antigen retrieval

• Block endogenous peroxidase activity with 3% H₂O₂

• Block non-specific binding with 5% normal goat serum in PBS

• Incubate with Os05g0539400 antibody at dilutions ranging from 1:100 to 1:500

• Incubate with appropriate detection system (HRP-polymer or biotinylated secondary antibody)

• Develop with DAB or other chromogen

• Counterstain, dehydrate, and mount

Critical Controls:

• Positive control: Tissue known to express Os05g0539400

• Negative control: Omission of primary antibody

• Absorption control: Pre-incubation of antibody with immunizing peptide

• Genetic control: Tissue from knockout/knockdown plants if available

Troubleshooting Strategies:

• Test multiple fixation times and methods

• Optimize antibody concentration and incubation times

• Consider using amplification systems for low-abundance targets

• Test multiple blocking reagents to reduce background

What are common causes of inconsistent results with Os05g0539400 antibody and how can they be addressed?

Inconsistent results when using Os05g0539400 antibody can be attributed to various factors. The following table outlines common issues, their potential causes, and recommended solutions:

When troubleshooting, it's recommended to systematically alter one variable at a time while maintaining careful documentation of all protocol modifications. For critical experiments, performing biological and technical replicates is essential to ensure reproducibility .

How can researchers validate the specificity of Os05g0539400 antibody in their experimental systems?

Validating antibody specificity is crucial for ensuring reliable experimental results. For the Os05g0539400 antibody, researchers should implement a multi-faceted validation approach:

1. Genetic Validation:

• Test antibody in Os05g0539400 knockout or knockdown plants (if available)

• Compare with wild-type samples to confirm specificity

• Use CRISPR-edited plant lines with tagged Os05g0539400 as positive controls

2. Biochemical Validation:

• Perform peptide competition assays by pre-incubating antibody with immunizing peptide

• Expected result: Signal should be abolished or significantly reduced

• Include gradient concentrations of competing peptide to demonstrate dose-dependency

3. Orthogonal Method Validation:

• Compare protein detection with an alternative method like mass spectrometry

• Correlate antibody signals with mRNA expression (RT-qPCR)

• Use different antibodies targeting the same protein (if available)

4. Bioinformatic Validation:

• Analyze cross-reactivity potential using sequence alignment tools

• Predict potential cross-reactive proteins in the experimental system

• Verify expected molecular weight matches observed band size

5. Experimental Controls:

• Include tissue-specific expression controls based on known expression patterns

• Use recombinant Os05g0539400 protein as positive control

• Include samples from related plant species as specificity controls

These validation approaches should be documented and reported alongside experimental findings to enhance confidence in antibody specificity. Additionally, researchers should consider registering validated antibody data in repositories to benefit the scientific community .

What strategies can improve detection sensitivity when working with low-abundance Os05g0539400 protein?

When the Os05g0539400 protein is present at low abundance, implementing the following strategies can significantly improve detection sensitivity:

Sample Enrichment Techniques:

• Subcellular fractionation to concentrate compartments where Os05g0539400 is predominantly localized

• Immunoprecipitation before analysis to concentrate the target protein

• Protein precipitation methods to concentrate total protein from dilute samples

• Size exclusion or ion exchange chromatography for partial purification

Detection Enhancement Methods:

• Signal amplification systems:

  • Tyramide signal amplification (TSA) can increase sensitivity 10-100 fold

  • Polymer-based detection systems with multiple HRP molecules

  • Quantum dot-conjugated secondary antibodies for fluorescence applications

• Extended exposure times for Western blots:

  • Use high-sensitivity ECL substrates with longer exposure times

  • Consider using cooled CCD camera systems for digital image acquisition

• Modified ELISA approaches:

  • Implement sandwich ELISA if a second compatible antibody is available

  • Use biotin-streptavidin amplification systems

  • Consider electrochemiluminescence-based ELISA platforms

Protocol Optimization:

• Reduce protein loss during sample preparation:

  • Minimize handling steps and transfers

  • Use low-binding tubes and pipette tips

  • Add carrier proteins to very dilute samples

• Optimize blocking and washing conditions:

  • Test different blocking agents (milk vs. BSA vs. casein)

  • Adjust washing stringency to balance background reduction with signal retention

  • Optimize antibody concentrations through careful titration

• Increase antibody binding efficiency:

  • Extend primary antibody incubation time (overnight at 4°C)

  • Optimize incubation temperature and buffer composition

  • Consider using antibody fragmentation (Fab, F(ab')2) to improve tissue penetration

Implementation of these strategies should be accompanied by appropriate controls to ensure that the enhanced signal remains specific to the target protein .